Neuronal migration and axon growth, key events during neuronal development, require distinct changes in the cytoskeleton. Although many molecular regulators of polarity have been identified and characterized, relatively little is known about their physiological role in this process. To study the physiological function of Rac1 in neuronal development, we have generated a conditional knock-out mouse, in which Rac1 is ablated in the whole brain. Rac1-deficient cerebellar granule neurons, which do not express other Rac isoforms, showed impaired neuronal migration and axon formation both in vivo and in vitro. In addition, Rac1 ablation disrupts lamellipodia formation in growth cones. The analysis of Rac1 effectors revealed the absence of the Wiskott-Aldrich syndrome protein (WASP) family verprolinhomologous protein (WAVE) complex from the plasma membrane of knock-out growth cones. Loss of WAVE function inhibited axon growth, whereas overexpression of a membrane-tethered WAVE mutant partially rescued axon growth in Rac1-knock-out neurons. In addition, pharmacological inhibition of the WAVE complex effector Arp2/3 also reduced axon growth. We propose that Rac1 recruits the WAVE complex to the plasma membrane to enable actin remodeling necessary for axon growth.
Introduction
Neuronal differentiation requires spatial and dynamic reorganization of the cytoskeleton. In particular, finely tuned actin filament organization and microtubule dynamics are essential for neuronal migration, axon growth, and guidance (Luo, 2000; da Silva and Dotti, 2002; Dent and Gertler, 2003; Kawauchi and Hoshino, 2008; . The Rho-GTPases Cdc42, Rac, and Rho, key regulators of the cytoskeleton, are implicated in these processes (Govek et al., 2005) . However, the physiological role of these molecules during neuronal development remains fragmentary.
Loss-of-function mutants of the Drosophila Rac genes show impaired axon growth, branching, and guidance (HakedaSuzuki et al., 2002; Ng et al., 2002) . The role of mammalian Rac proteins in axon development is less clear. Rac1 and Rac3 are present in the nervous system (Didsbury et al., 1989; Bolis et al., 2003) , and the expression of mutant Racs causes aberrant axon formation in mouse and chick neurons (Luo et al., 1996; Albertinazzi et al., 1998) . By contrast, deletion of Rac3 or specific ablation of Rac1 in the mouse cortex does not affect axon growth (Corbetta et al., 2005; Chen et al., 2007; Gualdoni et al., 2007; Kassai et al., 2008) . This suggests that axon growth may be independent of Rac activity. However, Rac3, which is also expressed in the cortex, could have a redundant function with Rac1 (Bolis et al., 2003; Corbetta et al., 2009 ). Thus, the physiological role of mammalian Racs in axon growth remains to be elucidated.
Apart from its debated role in axon growth, Rac1 may also be involved in regulating cell migration (Ridley, 2001a) . However, this idea has been challenged in recent in vivo studies, showing that Rac1 is dispensable for the migration of many neuronal and non-neuronal cells, including fibroblasts, macrophages, leukocytes, and cortical neurons (Bokoch, 2005; Vidali et al., 2006; Wheeler et al., 2006; Kassai et al., 2008) .
Among the Rho GTPases, Rac has a unique role in remodeling the actin cytoskeleton during lamellipodia formation (Nobes and Hall, 1995; Hall, 1998; Ridley, 2001b) . Rac regulates actin dynamics through two main downstream effector pathways, p21-activated kinase (PAK) and the Wiskott-Aldrich syndrome protein (WASP) family verprolin-homologous protein (WAVE) (Miki et al., 1998; Sells et al., 1999; Ridley, 2001a; Burridge and Wennerberg, 2004; Stradal et al., 2004) . PAK signals to the actin cytoskeleton via cofilin (Ng and Luo, 2004) , whereas WAVE induces cytoskeletal changes by direct interaction with the actinrelated protein 2/3 (Arp2/3) complex and profilin II (Takenawa and Miki, 2001 ; Pilo Boyl et al., 2007 ). Yet it remains unclear whether these pathways are activated during Rac1-mediated ac-quently incubated overnight with primary antibody diluted in blocking solution. The primary antibodies used were mouse monoclonal antineuron-specific nuclear protein (NeuN) (1:100; Millipore Bioscience Research Reagents) and anti-L1 (1:100; Abcam) and rabbit polyclonal anti-calbindin D-28K (1:100; Millipore Bioscience Research Reagents), anti-glial fibrillary acidic protein (GFAP) (1:400; Dako), anti-active caspase-3 (1:100; Promega), anti-neurofilament (150 kDa) (1:200; Millipore Bioscience Research Reagents), anti-phosphohistone H3 (1:100; Millipore), and anti-Ki-67 (1:50; Novocastra Laboratories). The sections were incubated with appropriate secondary antibodies conjugated to Alexa Fluor 488, 568, and 350 (Invitrogen) . Confocal images were acquired with an SP2 confocal microscope (Leica) in sequential scanning mode.
5-Bromo-2Ј-deoxyuridine labeling. P7-P8 mice were injected intraperitoneally with 50 mg/kg 5-bromo-2Ј-deoxyuridine (BrdU) (250 mg/ml DMSO stock; Sigma-Aldrich). Mice were perfused 24 or 96 h after injection. After denaturing the DNA (2N HCl; 40°C; 30 min), the brain sections were immunostained using a mouse anti-BrdU monoclonal antibody, clone MoBu-1 (1:400; Acris Antibodies).
Cerebellar microexplant culture. Microexplant cultures were prepared from the P5 external granule layer (EGL) as described previously (Nagata and Nakatsuji, 1990) . Cerebellar microexplants were fixed and stained with Tuj1 and 4Ј,6-diamidino-2-phenylindole (DAPI) (2 g/ml; Invitrogen).
Migration analysis. To assess migration, the number of DAPI-labeled migratory cells surrounding the explant was counted using the Scion Image 4.0.2 software. Explants were normalized according to their size, and results were expressed as number of migratory cells per square millimeter of explant area. To evaluate the distribution of migratory cells around the explant, we measured the occupancy area defined as the area that contained Ͼ90% of migratory cells.
Quantification of cell proliferation, apoptosis, and migration. Quantification of cell proliferation was performed by counting the number of phosphohistone H3-and Ki-67-positive cells in the EGL and molecular layer (ML) of three comparable nonadjacent midsagittal sections. Results were expressed as the number of proliferating cells per millimeter of EGL length. For quantification of cell death, the number of active caspase-3-positive cells in three comparable nonadjacent midsagittal sections was counted. Results were expressed as the number of proliferating cells per square millimeter of cerebellar surface. Quantification of cell migration was performed by counting the number of NeuN-positive cells in the ML of three comparable nonadjacent midsagittal sections. Results were expressed as the number of proliferating cells per micrometer of ML length.
DiI labeling of parallel fibers. P15 cerebella were fixed with 4% PFA, embedded in 3% agarose in PBS, and cut into 80 m coronal sections using a vibratome. Sections were mounted on a glass slide, and tissue was punctured with the lipophilic dye DiI (Invitrogen)-filled glass pipette (no pressure applied). The DiI-filled pipette was inserted beneath the pial surface, into the molecular layer of a cerebellum at the midline of folium pyramis vermis. To test for possible variations in the injection area, we performed 13 DiI injections in the cerebellar tissue and measured the labeled area. The mean injection diameter was 65 m, and the SD was Ϯ4 m (6%). Sections were incubated in 4% PFA at room temperature for 2-4 d and subsequently analyzed for parallel fiber extension using fluorescence microscopy. Fluorescent images were processed using Adobe Photoshop and Canvas software.
Cell culture and transfections. Primary culture of CGNs was prepared from the cerebellar cortex of P9 mice as described previously (Hatten, 1985; Ertürk et al., 2007) . Briefly, CGNs were dissociated using a trypsin (10 mg/ml)/DNase (1 mg/ml) mix and triturated to remove cellular aggregates. The granule cells were plated at densities of 300 -500 cells/mm 2 in 6 cm tissue culture dishes containing poly-L-lysine (1 mg/ml; SigmaAldrich)-coated glass coverslips and Neurobasal medium (Invitrogen) supplemented with 2% B27 (Invitrogen), 2 mM glutamine (Invitrogen), and 1% penicillin-streptomycin (Invitrogen). Transfections were performed using Amaxa Nucleofector (2 ϫ 10 6 cells in 100 l cell suspension with 5 g of DNA; Amaxa Biosystems). Various expression constructs or control plasmids were mixed with pEYFP-C1 as a transfection marker at a ratio of 4:1. Cells were analyzed 3 d after transfection.
For the RNA interference (RNAi) experiments, Nap1 short hairpin RNA (shRNA) and control vector were kindly provided by Dr. Eva Anton (University of North Carolina School of Medicine, Chapel Hill, NC) (Yokota et al., 2007) . To perform RNAi experiments, CGNs were transfected with 2 g of the Nap1 shRNA or control vector and plated into uncoated dishes to avoid cell attachment and differentiation. Twenty-four hours after plating, the cells were transferred into dishes containing coated glass coverslips and cultured as described above. Cells were analyzed after 2 d in vitro (DIV).
B16-F1 mouse melanoma cells were cultured as described previously (Steffen et al., 2004) . Transfections were performed using Superfect (QIAGEN). Transfected cells were plated onto laminin (Sigma-Aldrich)-coated coverslips and fixed after 5 h.
Immunocytochemistry. CGNs in dissociated cultures and microexplants were fixed and immunostained as described previously (Ertü rk et al., 2007) . B16-F1 cells were fixed and processed as described previously (Steffen et al., 2004) . The following mouse monoclonal primary antibodies were used: anti-␤III-tubulin, clone Tuj1 (1:20,000; Covance), anti-Tau-1, clone PC1C6 (1:5000; Millipore), anti-cortactin, clone 4F11 (1:500; Millipore), and anti-myc 9E10 (Abcam). The rabbit polyclonal primary antibodies used were as follows: anti-phospho Ser199/204 Pak1/Pak2 (1:500; Millipore), anti-Sra-1 (1:100), anti-Nap1 (1:7) (Steffen et al., 2004) , and anti-green fluorescent protein (GFP) (1:1000; Research Diagnostics). The mouse anti-Abi1 (1:50) and rabbit anti-pan-WAVE (1:100) antibodies were kindly provided by Dr. G. Scita (Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy) (Innocenti et al., 2005) . Secondary antibodies conjugated to Alexa Fluor 488 and rhodamine phalloidin were used (Invitrogen).
Live cell imaging and image acquisition. For time-lapse analysis of growth cone dynamics, coverslips with neurons were kept at 36°C in custom-made cell chambers filled with HEPES-buffered HBSS. Images were acquired on an Axiovert 135TV inverted microscope (Zeiss) equipped with standard filters for GFP, Texas Red, and DAPI, using high-performance CCD camera 4912 (Cohu) and Scion Image Beta 4.0.2 software for Microsoft Windows. Adobe Photoshop 8 (Adobe Systems) and Canvas (ACD Systems) were used for processing and annotation of the images. Process lengths and growth cone areas were measured using the Scion Image software. Statistical significance ( p value) was calculated using Student's t test.
For long-term time-lapse analysis of neurite formation and short-term treatments with Arp2/3 inhibitor, CGNs were imaged in 3.5 cm glassbottom dishes to which 20 mm coverslips were adhered to the bottom with aquarium sealant. For long-term experiments, imaging was performed in culture medium. Images were acquired using a DeltaVision RT (Applied Precision) live-cell imaging setup based on an Olympus IX71 inverted microscope with a CO 2 -regulated incubation chamber maintained at 36°C (Solent Scientific). Imaging was performed with a 60ϫ, numerical aperture 1.6 objective (Olympus). Images were acquired with a Photometrics CoolSnap HQ camera (Roper Scientific) using SoftWoRx 3.5.0 imaging software (Applied Precision).
F-actin assay. For quantifications of F-actin amounts, CGNs were cultured as described above, fixed, and permeabilized at 1.5 DIV in PHEM buffer (60 mM PIPES, 25 mM HEPES, 5 mM EGTA, 1 mM MgCl) containing 0.25% glutaraldehyde, 3.7% PFA, 3.7% sucrose, and 0.1% Triton X-100 and costained for Tuj1 and phalloidin. Images were captured with 100ϫ (1.6ϫ) objective at below saturation (one to four frames). The average intensity of F-actin was measured in growth cones. Background intensity was measured in nearby region and subtracted. F-actin levels were normalized to controls, thereby correcting for differences in stainings from different experiments.
Drug treatment. Cytochalasin D (Sigma-Aldrich) was dissolved in DMSO at 10 mM and applied to neuronal cultures 4 h after plating at a final concentration of 1 M. Cells were analyzed at 1 and 2 DIV.
The Arp2/3 inhibitor CK-548 (ChemDiv) was dissolved in DMSO at 100 mM and applied to neuronal cultures 4 h after plating at a final concentration of 50 M. After 1 DIV, another 50 M of the inhibitor was added to the cells. Cells were fixed at 2.5 DIV and immunostained for Tuj1. The length of the longest Tuj1-stained neurite was quantified. For short-term time-lapse observations of growth cone motility, cells were cultured for 1 DIV and then imaged at 5 s intervals for 15 min before adding the Arp2/3 inhibitor (50 M) to observe the growth cone dynamics and continuously imaged for 30 min after addition of the drug.
RhoA and Cdc42 activation assay. To measure the activities of RhoA and Cdc42, G-LISA RhoA and Cdc42 Activation Assay Biochem kits (Cytoskeleton) were used. Results were expressed as the ratio between absorbance at 490 nm (A 490 ) in wild-type and Rac1 Ϫ/Ϫ extracts. 
Results

Deletion of Rac1 in the nervous system
Rac1 depletion from the germ line results in lethality at early embryonic day 9.5 (Sugihara et al., 1998) . To study the function of Rac1 in the developing nervous system, we crossed mice carrying a floxed Rac1 allele (Chrostek et al., 2006 ) with a mouse line expressing Cre recombinase under the control of a nestin promoter (Tronche et al., 1999; Graus-Porta et al., 2001 ). Both Rac1 and its highly homologous isoform Rac3 are expressed in the cortex, whereas Rac1 represents by far the predominant form in the cerebellum (Bolis et al., 2003) .
To confirm that the expression of Cre leads to the excision of Rac1 and the absence of Rac isoforms in the cerebellum, cerebellar and cortical protein extracts were analyzed using a Rac1 antibody that also cross-reacts with Rac3. Cortical extracts from Rac1-deficient animals contained Rac protein, which can be attributed to the presence of Rac3 (Fig. 1A) . By contrast, Rac protein was virtually absent in cerebellar extracts of P0 -P9 Rac1-deficient animals ( Fig.  1A ) (data not shown). Lack of Rac3 expression in the cerebellum precludes a compensatory mechanism by this isoform, making the developing cerebellum uniquely suited to study the cellular role of Rac1 in neuronal development.
Newborn Rac1 Ϫ/Ϫ pups were obtained at a normal mendelian ratio. Around P10, Rac1 Ϫ/Ϫ littermates became distinguishable from the wild-type and heterozygous pups based on their smaller size. Rac1-deficient animals showed a resting tremor, clenching of the hindlimbs, and poor balance (data not shown). Rac1
ϩ/Ϫ pups showed no obvious phenotypic changes compared with wild type.
The Rac1 Ϫ/Ϫ brains were already at P9 smaller than wild-type brains (supplemental Fig. S1 A, available at www.jneurosci.org as supplemental material). Morphological analysis of Nissl-stained brain sections showed that all brain regions in Rac1-deficient animals were reduced in size (supplemental Fig. S1 B, C, available at www.jneurosci.org as supplemental material). Moreover, the ventricles were enlarged (supplemental Fig. S1 B, arrowhead, available at www.jneurosci.org as supplemental material) (data not shown), and the neuroepithelium was thicker than in wildtype brains (supplemental Fig. S1C , available at www.jneurosci. org as supplemental material). Nissl staining did not reveal major abnormalities within the cerebral cortex and the hippocampus (supplemental Fig. S1C , available at www.jneurosci.org as supplemental material).
In contrast, we found profound changes within the cerebellum of the Rac1-deficient animals (supplemental Fig. S1 B, available at www.jneurosci.org as supplemental material). First, the cerebellum was significantly reduced in size. Staining cerebellar sections with an antibody against active caspase-3 revealed a threefold increase in the number of apoptotic cells in the P0 -P1 Rac1-knock-out cerebellum (supplemental Fig. S2 A, B, available at www.jneurosci.org as supplemental material), which could contribute to the observed brain size reduction. Similarly, the number of apoptotic cells increased in the Rac1-null cortex at P0 -P1, indicating that Rac1 and Rac3 may have non-overlapping functions in cell survival (data not shown). Later during cerebellar development, the number of apoptotic cells in wild-type and Rac1-knock-out animals was similar (supplemental Fig. S2 A, B, available at www.jneurosci.org as supplemental material). We found no evidence for decreased cell proliferation that could contribute to cerebellar size reduction. Quantification of phosphohistone H3-and Ki-67-positive cells showed no differences between Rac1-knock-out and wild-type cerebella at the analyzed stages P0 -P1, P8 -P10, and P18 (supplemental Fig. S2C ,D, available at www. jneurosci.org as supplemental material) (data not shown).
Apart from the reduction in size, the Rac1 Ϫ/Ϫ cerebellum showed an enlarged fourth ventricle (supplemental Fig. S1B , arrowhead, available at www.jneurosci.org as supplemental material), a complete loss of the second, third, fourth, and fifth cerebellar lobe (supplemental Fig. S1B , lobes indicated in the wild type, available at www.jneurosci.org as supplemental material), as well as foliation defects (supplemental Fig. S1B , available at www.jneurosci.org as supplemental material). In addition, cerebellar structures were located between the brainstem and the enlarged inferior colliculus in the Rac1-null cerebellum in contrast to the wild-type brain (supplemental Fig. S1B , asterisk, available at www.jneurosci.org as supplemental material). Thus, Rac1 ablation leads to strong defects in cerebellar development and organization.
Rac1-knock-out CGNs show defects in migration
Neuronal migration is one early polarized event during neuronal development. To test whether neuronal migration is impaired in the absence of Racs, we focused on CGNs that express only Rac1. We stained cerebellar sections with antibodies against the CGN Ϫ/Ϫ CGNs. A, Dividing cerebellar granule cell precursors were labeled by systemic injection of BrdU into P7 wild-type and Rac1-deficient mice. At 24 h after BrdU injection, the majority of BrdU-labeled granule cells are in the EGL in both the wild-type and Rac1 Ϫ/Ϫ cerebellum (arrowheads). At 96 h after injection, the majority of BrdU-labeled granule cells in the wild-type cerebellum have reached the IGL (arrowhead). By contrast, in the Rac1 Ϫ/Ϫ cerebellum, more BrdU-labeled granule cells (arrowheads) stayed in the EGL and ML. Scale bar, 50 m. B, EGL explants from P5 wild-type and Rac1 Ϫ/Ϫ mice were stained with DAPI after 2 DIV. Rac1 Ϫ/Ϫ neurons migrate from the explant less efficiently than wild-type neurons. Scale bar, 200 m.
markers NeuN and Pax-6 (Yamasaki et al., 2001; Weyer and Schilling, 2003) . In the P18 wild-type cerebellum, NeuNpositive CGNs were almost exclusively present in the internal granule layer (IGL) (Fig. 1 B) . By contrast, in the Rac1-null cerebellum, we found a fivefold increase in the number of NeuN-positive cells in the ML compared with control (1.1 Ϯ 0.2 in Rac1-null vs 0.2 Ϯ 0.1 cells in wild type; average Ϯ SEM/micrometers of ML from three animals; n ϭ 3 sections/cerebellum; p Ͻ 0.05) (Fig. 1B, arrowheads) . Similarly, Pax-6-positive cells were still present in the EGL and ML of the P18 Rac1 Ϫ/Ϫ cerebellum (data not shown).
In contrast to the aberrant localization of CGNs, Purkinje neurons, which express Rac3 (Bolis et al., 2003) , formed their typical monolayer in the P18 Rac1-null cerebellum (Fig. 1C) . We also examined the in vivo organization of Bergmann glia by immunocytochemistry using the GFAP, but found no obvious differences between wild-type and Rac1-knock-out cerebella (Fig. 1D) . The majority of Rac1
CGNs were in close proximity to GFAPpositive glia fibers (Fig. 1D, arrowheads) .
To directly analyze inward migration of CGNs, we labeled dividing granule cell precursors by injecting BrdU in P7-P8 pups (Borghesani et al., 2002) . At 24 h after injection, BrdU-labeled cells resided in the EGL in both the wild-type and Rac1 Ϫ/Ϫ cerebellum ( Fig. 2 A, arrowheads). At 96 h after injection, wild-type BrdU-labeled cells had reached the IGL, whereas many Rac1 Ϫ/Ϫ BrdU-labeled cells resided within the EGL and ML (Fig.  2 A, arrowheads) . These results indicate a defect in migration of CGNs in the absence of Rac1.
Although we found Rac1-knock-out CGNs in close proximity with Bergmann glia fibers, we could not exclude the possibility that the loss of Rac1 interferes with the ability of neurons to associate and/or dissociate with the glia fibers, resulting in an impaired neuronal migration. To test whether the migration defect in the Rac1-null CGNs is cell autonomous, we studied their migration in cultured EGL microexplants (Fig. 2 B) . As reported previously Nakatsuji, 1990, 1994) , we confirmed that cells migrating out of the explants are CGNs (data not shown). Their migration in microexplants occurs independently of Bergmann glia, making this system well suited to study cell-autonomous migratory cues Nakatsuji, 1990, 1994) . After 2 DIV, we found more than a twofold decrease in the number of Rac1-knock-out granule cells migrating out of the explant compared with wild-type (913.8 Ϯ 140 in Rac1-knockout vs 2231 Ϯ 322.1 cells in wild type; average Ϯ SEM/square micrometers of explant surface from five independent cultures; n ϭ 100 explants; p Ͻ 0.01) (Fig. 2 B) . Furthermore, Rac1-knockout granule neurons migrated far shorter distances and distributed over smaller occupancy area compared with migrating wildtype neurons (0.2 Ϯ 0.1 in Rac1-knock-out vs 0.5 Ϯ 0.1 mm 2 in wild type; average Ϯ SEM from five independent cultures; n ϭ 100 explants; p Ͻ 0.001). Together, our data demonstrate that Rac1 is necessary for the migration of CGNs in a cellautonomous fashion. Ϫ/Ϫ neurons show deficient axon extension in vivo. A, P15 coronal sections from the middle part of the cerebellum immunostained with an antibody against L1 that visualizes parallel fibers in the ML. Images of boxed regions of the ML are depicted at higher magnification. L1 immunostaining reveals less densely packed parallel fibers in the ML of the Rac1-null cerebellum compared with wild type (arrows). Scale bars, 30 m. B, P18 midsagittal sections immunostained with an antibody against neurofilament to visualize axons. Images of boxed regions of the ML are depicted at higher magnification. Long axonal fibers can be observed in the wild-type cerebellum and short and misrouted axons in the Rac1 Ϫ/Ϫ cerebellum (arrows). Scale bars, 30 m. C, DiI-labeled parallel fibers in P15 coronal sections of wild-type and Rac1 Ϫ/Ϫ cerebella. At 2 d after DiI injection, parallel fiber labeling within the ML is visible in the wild-type cerebellum (asterisks), but not in the Rac1 Ϫ/Ϫ cerebellum. At 4 d after injection, long parallel fibers project from both sides of the DiI injection place in the wild-type cerebellum, but this labeling is absent in the Rac1 Ϫ/Ϫ cerebellum. The pial surface of the cerebellum is indicated by arrowheads. Note that the intensity of DiI labeling at the injection site in wild-type and Rac1 Ϫ/Ϫ cerebellum is comparable (2 d after DiI injection). Scale bar, 100 m.
Rac1-knock-out
et al., 2001). During radial migration, CGNs extend two axons, the parallel fibers, that reside in the ML and can be visualized with an antibody against the cell adhesion molecule L1 (Fig. 3A ) (Sakurai et al., 2001 ). In the Rac1 Ϫ/Ϫ cerebellum, only few L1-positive axons were observed (Fig. 3A, arrows) . Moreover, axonal fibers in the ML visualized by neurofilament immunostaining were short and misoriented (Fig. 3B, arrows) . To further analyze axonal tracts in vivo, we injected DiI in the wild-type and Rac1-knock-out cerebella (Fig. 3C) . At 2 d after DiI injection, labeled axons of CGNs were visible in the wild-type (Fig. 3C, asterisks) , but not in the Rac1-knock-out cerebellum. At 4 d after DiI injection, typical bipolar and parallel axonal tracts extended over distances Ͼ400 m from the injection site in the wild-type cerebellum (Fig. 3C, asterisks) . In contrast, no axonal labeling was observed in the Rac1-knock-out cerebellum. This suggests that Rac1 signaling is critically required during parallel fiber formation. Of note, Rac1-knock-out Purkinje cells, which express Rac3, do not show defects in extending their axon (Fig.  1C, arrowheads) .
To assess whether Rac1 affects axon growth in a cellautonomous manner, when separated from spatial cues, we examined axon formation in dissociated CGNs, an established model of neuronal polarity (Hatten and Heintz, 1995; Powell et al., 1997; Zmuda and Rivas, 1998) . Cultured CGNs undergo a set of well described morphological changes that resemble those occurring in vivo (Powell et al., 1997) . Long neurites that develop after 2 DIV correspond to axons and can be morphologically distinguished from dendrites, whose development initiates at later stages (5-6 DIV). We found a threefold decrease in the number of Rac1 Ϫ/Ϫ neurons that extended axons Ͼ100 m after 2 DIV (Fig. 4 A, B) . Additionally, we assessed the ability of Rac1-knock-out CGNs to form axons. To this end, we used the Tau-1 antibody that recognizes a dephosphorylated Tau epitope that is axon specific (Mandell and Banker, 1996) . We found a 50% reduced ability of Rac1-knock-out CGNs to form axons compared with wild type (supplemental Fig. S3 , available at www.jneurosci. org as supplemental material). These data suggest a role of Rac1 in axon growth. Interestingly, Rac1 Ϫ/Ϫ neurons showed an increase in the average number of neurites per cell. Whereas Ͼ80% of wild-type neurons had one to two neurites per cell, the majority of Rac1 Ϫ/Ϫ neurons contained three or more neurites (Fig.  4 A, C) . Nevertheless, the average length of all neurites at 2 DIV decreased from 147.8 Ϯ 5.1 m in wild-type neurons to 113.4 Ϯ 1.4 m in Rac1-null CGNs (average Ϯ SEM from three independent cultures; n ϭ 100 cells/culture; p Ͻ 0,05). Time-lapse videomicroscopy analysis revealed that Rac1-null neurons initiated neurite formation at the same time as wildtype neurons (supplemental Fig. S4 A, B , Videos 1, 2, available at www.jneurosci.org as supplemental material). We observed a constant growth rate of both wild-type and Rac1-null neurons during the first 24 h. Wild-type neurons exhibited a growth rate of 1.5 m/h. Instead, Rac1 Ϫ/Ϫ neurons elongated their longest neurite slowly, with a growth rate of 0.8 m/h. After 24 h, wild-type neurons continued extending their axons further (supplemental Fig. S4 B, available at www.jneurosci. org as supplemental material), whereas Rac1 Ϫ/Ϫ neurons formed additional neurites (supplemental Fig. S4C , available at www.jneurosci.org as supplemental material).
To examine whether the defect in axon outgrowth was specifically caused by Rac1 ablation, we coexpressed wild-type Rac1 and YFP in Rac1 Ϫ/Ϫ CGNs. The length of the longest process increased by Ͼ50% on overexpression of Rac1 in Rac1 Ϫ/Ϫ neurons compared with Rac1 Ϫ/Ϫ neurons transfected with the control plasmid (Fig. 4 D) . On Rac1 overexpression, we could no longer observe a significant reduction of neurite length between wild-type and Rac1 Ϫ/Ϫ CGNs (Fig. 4 D) . Additionally, overexpression of Rac1 in Rac1-deficient neurons decreased the average number of neurites per cell (Fig. 4 E) . The majority of Rac1 Ϫ/Ϫ neurons transfected with Rac1 contained one to two neurites. Overexpression of Rac1 in wild-type neurons affected neither their neurite length nor their number of neurites (Fig. 4 D, E) . Similar to Rac1, we found that overexpressing Rac3 in Rac1-null neurons significantly increased the length of the longest process (supplemental Fig. S5C , available at www.jneurosci.org as supplemental material) and reduced neurite number (data not shown), whereas it had no effect in wild-type neurons. This suggests that Rac3 and Rac1 have overlapping functions in axon growth.
Figure 4. Reduced length and an increased number of neurites in cultured Rac1
Ϫ/Ϫ CGNs can be reversed by overexpressing Rac1. A, Dissociated CGNs were immunostained after 2 DIV with an antibody against Tuj1. Rac1 Ϫ/Ϫ CGNs display several shorter Tuj1-positive neurites, whereas wild-type CGNs typically exhibit one or two longer Tuj1-positive neurites. Scale bar, 25 m. B, Quantification of the length of the longest Tuj1-stained neurite. The values represent averages Ϯ SEM from three independent cultures (n ϭ 100 cells/culture; ***p Ͻ 0.001; **p Ͻ 0.01). C, Quantification of the neurite number. The values represent averages Ϯ SEM from three independent cultures (n ϭ 100 cells/culture; *p Ͻ 0.05). D, Quantification of the length of the longest neurite in CGNs cotransfected with pEYFP-C1 and pcDNA3.1 (ctrl) or with pEYFP-C1 and pRac1 (pRac1) at 3 DIV. The values represent averages Ϯ SEM from four independent cultures (n ϭ 100 cells/culture; **p Ͻ 0.01). E, Quantification of the neurite number in CGNs cotransfected with pEYFP-C1 and pcDNA3.1 (ctrl) or with pEYFP-C1 and pRac1 (pRac1) at 3 DIV. The values represent averages Ϯ SEM from three independent cultures (n ϭ 100 cells/culture; *p Ͻ 0.05).
Rac1
؊/؊ neurons lack lamellipodia To investigate whether the defect in axon formation is caused by aberrant regulation of the actin cytoskeleton, we stained cultured CGNs from wild-type and Rac1-knock-out animals with fluorescently labeled phalloidin. Lamellipodia were visualized using an antibody against cortactin ( Wu and Parsons, 1993) . Wild-type growth cones contained both long and thin actin protrusions, filopodia (Fig. 5A,  arrowhead) , and fanlike lamellipodia (Fig. 5A, arrow) . By contrast, Rac1-null neurons were typically devoid of lamellipodia (Fig. 5A) . Quantification of the proportion of cells bearing lamellipodia showed a 70% reduction in the Rac1-null CGNs compared with wild type (21.4 Ϯ 4.1 in Rac1-null vs 71 Ϯ 1.7% in wild type; average Ϯ SEM from three independent cultures; n ϭ 100 cells/culture; p Ͻ 0.01). Consistent with the absence of lamellipodia, we found that the growth cone surface of the Rac1-deficient CGNs reduced to 44.3 Ϯ 1.6% of the wild-type growth cone surface (average Ϯ SEM from three independent cultures; n ϭ 20 cells/culture; p Ͻ 0.001). Additionally, Rac1-null neurites typically showed actin-rich filopodia at their ends (Fig. 5A, arrowheads) . Examination of cultured CGNs by videomicroscopy revealed dynamic filopodia in wild-type and Rac1-knock-out neurons ( Fig. 5B ; supplemental Videos 3, 4, available at www.jneurosci.org as supplemental material), but the specific absence of lamellipodia dynamics in Rac1-null CGNs (supplemental Video 4, available at www. jneurosci.org as supplemental material). We also observed that the relative amount of F-actin in the Rac1-knock-out growth cones reduced to 49 Ϯ 1% of the wild type (average Ϯ SEM from four independent cultures; n ϭ 100 cells/culture; p Ͻ 0.01). Thus, our data demonstrate that Rac1 is essential for lamellipodia formation and growth cone dynamics of CGNs.
Modulating the actin cytoskeleton increases the ability of Rac1-knock-out neurons to form axons Actin dynamics orchestrate neuronal polarization and axon growth. In fact, depolymerization of the actin cytoskeleton induces formation of multiple axons in dissociated hippocampal neurons Dotti, 1999, 2000; Kunda et al., 2001; Schwamborn and Püschel, 2004) . We wondered whether the observed changes in the actin cytoskeleton of Rac1-null neurons are underlying defects in neuronal polarization. We therefore pharmacologically depolymerized the actin cytoskeleton and assessed axon growth in Rac1 Ϫ/Ϫ CGNs (Fig. 6 A-C) . Cytochalasin D treatment of Rac1 Ϫ/Ϫ CGNs increased by 2.4-fold the length of the longest neurite (Fig. 6A,C) and by 2-fold the ability to form Tau-1-positive axons (Fig. 6 A, B) . Cytochalasin D treatment of Rac1 Ϫ/Ϫ CGNs also decreased their neurite number (Fig. 6 D) . In contrast to hippocampal neurons, we did not observe the formation of multiple axons on treatment of CGNs with cytochalasin D as previously reported (Zmuda and Rivas, 2000) . These differences may stem from different intrinsic developmental properties of these two distinct neuronal populations. Together, our work reveals that depolymerization of the actin cytoskeleton by cytochalasin D abrogated the difference in axon growth and neurite number between Rac1-knock-out and wild-type CGNs. Modest stabilization of microtubules also induces the growth of multiple axons in dissociated hippocampal neurons (GomisRüth et al., 2008; and enhances neurite outgrowth of CGNs when plated on the inhibitory substrate myelin (Ertürk et al., 2007) . However, treating Rac1 Ϫ/Ϫ CGNs with the microtubule-stabilizing drug Taxol did not affect their neurite length (data not shown). Therefore, our experiments suggest that Rac1 predominantly regulates neurite outgrowth via modulating the organization of the actin cytoskeleton. Ϫ/Ϫ CGNs lack lamellipodia and show reduced actin dynamics. A, Dissociated CGNs at 1.5 DIV were costained with rhodamine-phalloidin to visualize actin filaments and with an antibody against cortactin to visualize lamellipodia. Images from wild-type and two different Rac1 Ϫ/Ϫ neurons are shown. Cortactin and phalloidin staining of a wild-type neuron reveal a lamellipodium (arrow) and a filopodium (arrowhead), whereas Rac1 Ϫ/Ϫ neurons only have filopodia at their neurite tips (arrowheads) but lack lamellipodia. Scale bar, 10 m. B, Time-lapse videomicroscopy of representative wild-type and Rac1 Ϫ/Ϫ CGNs at 1.5 DIV. Three frames at 1 min intervals are shown. A dynamic lamellipodium of a wild-type growth cone is indicated by an arrow. A filopodium of a Rac1 Ϫ/Ϫ growth cone is indicated by an arrowhead. Scale bar, 10 m.
Rac1-knock-out cerebella show a decrease in PAK1 phosphorylation
Since expression of constitutively active Rac in fibroblasts causes a decrease in Rho activity (Sander et al., 1999) , we examined whether there was a cross talk between Rac1 and RhoA in the cerebellum. However, neither total RhoA expression levels (data not shown) nor the levels of active RhoA in Rac1 Ϫ/Ϫ cerebellar extracts were altered (Fig. 7A) . We also did not find any change in Cdc42 activation in Rac1-null compared with wild-type cerebellar extracts (Fig. 7A) . This indicates that defects in the Rac1 Ϫ/Ϫ cerebellum are not mediated through RhoA or Cdc42 signaling.
We assessed potential effectors of Rac1 that regulate actin dynamics. Previous work showed that PAK1 regulates axon formation in hippocampal neurons (Jacobs et al., 2007) . We observed a decrease in the phosphorylation of PAK1 at Ser 198/203 in Rac1 Ϫ/Ϫ cerebellar extracts (Fig. 7B) , indicating a reduced catalytic activity of PAK1 (Shamah et al., 2001 ). The total PAK1 protein levels remained constant (Fig. 7B) . Decrease in the phosphorylation of PAK1 was mainly attributable to decreased levels of phosphorylated PAK in neurites of Rac1 Ϫ/Ϫ CGNs (Fig. 7C) . We attempted to rescue the growth defect of Rac1-knock-out neurons by manipulating PAK1. Transfection of a phosphomimetic PAK1 mutant (PAKT423E) caused no increase in neurite length (Fig. 7D ) or number (data not shown) in Rac1-knock-out neurons, suggesting that activating PAK1 alone is not sufficient to rescue axon formation. It has been shown that membranetargeting and kinase activity of PAK1 are required for axon formation in hippocampal neurons (Jacobs et al., 2007) . However, overexpression of the membrane-targeted PAK1 construct (Pak1-CAAX) also did not rescue neurite length or axon formation in Rac1-knock-out neurons (supplemental Fig. S5D , available at www.jneurosci.org as supplemental material) (data not shown). In another study, it has been shown that overexpression of the kinase-dead, membrane-targeted form of PAK1 (PakR299-CAAX) induces neurite outgrowth in PC12 cells, suggesting that the effect of PAK1 on neurite outgrowth is independent of its kinase activity but requires membrane localization (Daniels et al., 1998) . We therefore also overexpressed a PakR299-CAAX in Rac1 Ϫ/Ϫ CGNs, but failed to detect an increase in neurite length or axon formation (supplemental Fig. S5E , available at www. jneurosci.org as supplemental material) (data not shown).
We also analyzed the activity of the PAK effector cofilin, an F-actin depolymerizing and severing factor that affects axon formation in hippocampal neurons (Garvalov et al., 2007; Jacobs et al., 2007) but found no detectable differences in phosphorylation of cofilin between wild-type and Rac1-knock-out cerebellar extracts (Fig. 7E) . Together, our data suggest that Rac1 regulates axon growth through pathways other than PAK-cofilin.
Rac1-knock-out neurons mislocalize the WAVE complex from the growth cone plasma membrane
Overexpression studies in fibroblasts and melanoma cells have shown that the WAVE complex regulates lamellipodia formation and that Rac1 is necessary for its recruitment to the plasma membrane (Steffen et al., 2004) . The WAVE complex, comprising WAVE, Sra-1, Nck-associated protein 1 (Nap1), Abelson- interacting protein 1 (Abi1), and HSPC300, has been implicated in axon development in vertebrate and invertebrate neurons (Hummel et al., 2000; Bogdan et al., 2004; Kawano et al., 2005; Yokota et al., 2007) . We therefore assessed whether WAVE signaling is disturbed in Rac1-knock-out neurons. First, we investigated protein levels of the WAVE complex components Sra-1, Nap1, and WAVE, but could not detect any differences between wild-type and Rac1-knockout brains (Fig. 8 D) . As WAVE recruitment to the plasma membrane is crucial for its signaling (Steffen et al., 2004; Stradal et al., 2004) , we analyzed the intracellular localization of WAVE protein using a pan-WAVE antibody. In wildtype neurons, WAVE localized to the plasma membrane of lamellipodial protrusions ( Fig. 8 A, B) . By contrast, in Rac1-knock-out neurons, WAVE was absent from the plasma membrane (Fig. 8 A, B) . As the vast majority of Rac1 Ϫ/Ϫ neurons contained no lamellipodia (Fig. 5B) , we selected for the rare Rac1 Ϫ/Ϫ neurons that still contained some lamellipodia-like protrusions. Even in those neurons, WAVE, as well as other components of the WAVE complex, including Abi1, Sra-1 (Fig. 8 A-C) , and Nap1 (data not shown), failed to localize to the plasma membrane of the growth cone. Only 20 -30% of the Rac1-knock-out neurons containing some lamellipodia remnants showed Abi1, Sra-1, and WAVE localization at the plasma membrane of the growth cone (Fig.  8C) . These results suggest that Rac1 regulates the WAVE complex activity by localizing it to the plasma membrane of neuronal growth cones.
The WAVE complex and its downstream effector Arp2/3 regulate axon growth We hypothesized that Rac1-deficient neurons show defects in axon growth because the WAVE complex cannot be efficiently recruited to the plasma membrane. To test this, we generated a WAVE1 mutant fused to a Ras prenylation sequence (WAVE-CAAX). Plasma membrane localization of the WAVE-CAAX was confirmed in B16F1 mouse melanoma cells (supplemental Fig. S5 A, B , available at www. jneurosci.org as supplemental material). WAVE-CAAX overexpression in Rac1-knock-out CGNs caused a 50% increase in the number of cells forming Tau-1-positive axons (Fig. 9 A, B) and a 35% increase in the axon length (Fig. 9 A, C) . Additionally, overexpression of WAVE-CAAX in Rac1-knock-out CGNs resulted in a decreased neurite number (data not shown). We did not observe any changes in axon growth ( Fig. 9A-C) or neurite number (data not shown) in wildtype CGNs on overexpression of WAVE-CAAX construct. Furthermore, we did not observe an additional increase in axon growth in Rac1-knock-out neurons when WAVE-CAAX was co- Ϫ/Ϫ and wild-type cerebella. Cortical extracts were used as control. B, Analysis of phospho-PAK1 (p-PAK1) and PAK1 protein levels from P9 cortices and cerebella. Rac1 Ϫ/Ϫ cerebellar extracts show reduced levels of p-PAK1 compared with wild-type extracts. C, Dissociated CGNs at 2 DIV were immunostained with an antibody against p-PAK1/2. A decreased level of p-PAK1/2 can be observed in neurites of Rac1 Ϫ/Ϫ CGNs. By contrast, higher levels of p-PAK1/2 accumulate in a neurite of a wild-type CGN. Scale bar, 15 m. D, Quantification of the length of the longest neurite in CGNs cotransfected with pEYFP-C1 and pcDNA3.1/myc-His A (ctrl) or pEYFP-C1 and pPAKT423E (pPAKT423E) at 3 DIV. The values represent averages Ϯ SEM from three independent cultures (n ϭ 100 cells/culture; *p Ͻ 0.05; **p Ͻ 0.01). Overexpression of constitutively active PAK1 (PAKT423E) in Rac1 Ϫ/Ϫ CGNs does not increase neurite length. E, Analysis of phosphorylated-cofilin (p-cofilin) and cofilin protein levels from P9 cortices and cerebella. Wild-type and Rac1 Ϫ/Ϫ extracts show comparable levels of p-cofilin.
transfected with Pak299R-CAAX (supplemental Fig. S5F , available at www.jneurosci.org as supplemental material) or PAK-CAAX (data not shown).
We next tested whether the WAVE complex is necessary for axon growth in CGNs. It has been shown that disrupting WAVE signaling by knocking down the WAVE complex component Nap1 leads to axon growth defects in cortical neurons (Yokota et al., 2007) . Consistently, we observed a 2.1-fold decrease in length of the longest process in Nap1 shRNA-expressing neurons at 2 DIV compared with control (11.9 Ϯ 0.7 on Nap1 shRNA expression vs 25.6 Ϯ 1.9 m in control; average Ϯ SEM from three independent cultures; n ϭ 100 cells/culture; p Ͻ 0.05).
As WAVE regulates the actin cytoskeleton through the Arp2/3 complex, we tested whether Arp2/3 is necessary for axon growth in CGNs. To this end, we treated wild-type neurons with the pharmacological Arp2/3 inhibitor CK-548 (Nolen et al., 2009 ). CK-548 treatment reduced the length of the longest neurite by 50% (119.7 Ϯ 9.5 in DMSO-treated control vs 59.4 Ϯ 10 m in CK-548-treated cells; average Ϯ SEM from three independent cultures; n ϭ 100 cells/culture; p Ͻ 0.05). Time-lapse videomicroscopy analysis revealed that CK-548 treatment of wild-type CGNs drastically reduced lamellipodia formation, whereas filopodia dynamics remained intact (Fig. 9D) . Together, these data suggest that Rac1 regulates axon growth through the WAVE complex, which mediates its effects onto the actin cytoskeleton through the Arp2/3 complex.
Discussion
The cytoskeleton regulates the development of the nervous system, including proliferation, migration, and axon growth. The Rho family of GTPases, orchestrators of dynamic actin and microtubular network, appears to play a key role in neuronal development. However, our knowledge about their specific physiological function in the mammalian nervous system is only fragmentary. Using a brain-specific knock-out, we studied the role of Rac1 in neuronal migration and axon growth. We focused our analysis on the cerebellum as other Rac members are widely absent from this tissue (Bolis et al., 2003) and can therefore not substitute for the functions of Rac1. Our study shows that Rac1, by regulating actin cytoskeleton dynamics in neuronal growth cones, is a physiological regulator of neuronal migration and axon growth.
Neuronal migration requires Rac1 function
Rac1 was proposed to regulate cell migration (Ridley, 2001a Ϫ/Ϫ neurons mislocalize WAVE from the growth cone plasma membrane. A, Dissociated CGNs at 1 DIV were costained with rhodamine-phalloidin and an antibody against WAVE (pan-WAVE). Rac1 Ϫ/Ϫ neurons that still contained some lamellipodia-like protrusions were examined for WAVE localization. Scale bar, 10 m. B, Merged images of boxed regions in A are depicted at higher magnification. WAVE is absent from the edges of Rac1 Ϫ/Ϫ growth cones, whereas in wild-type neurons WAVE predominantly localizes to membranes of lamellipodial protrusions (arrowhead). Scale bar, 5 m. C, Quantification of plasma membrane localization of Abi1, Sra-1, and WAVE. CGNs, showing plasma membrane localization of the respective protein in at least one growth cone, were scored as positive. The values represent averages Ϯ SEM from three independent cultures (n ϭ 100 cells/culture; *p Ͻ 0.05; **p Ͻ 0.01; ***p Ͻ 0.001). D, Mislocalization of the WAVE complex in the Rac1 Ϫ/Ϫ neurons is not caused by protein degradation. Western blot analysis of P9 cortical and cerebellar extracts reveals no difference in the protein amounts of the respective WAVE complex components.
restricted Rac1-knock-out mice is not impaired (Kassai et al., 2008) . Here, we showed that Rac1 signaling is essential for efficient migration of one of the largest population of neurons in the brain, CGNs. Although one interpretation could be that Rac1 regulates migration in a neuron-specific manner, we favor the hypothesis that Rac3 functions in a redundant fashion with Rac1. Hence, the role of Rac1 in the cortex may be masked because of the presence of Rac3. In line with this idea, we found that Rac1-deficient Purkinje cells, which express Rac3 (Bolis et al., 2003) , were able to form their typical monolayer.
Apart from regulating neuronal migration, we found that Rac1 was important for neuronal survival. Thus, our in vivo data support previous cell culture overexpression studies (Linseman et al., 2001; Le et al., 2005) and reveal antiapoptotic effects of Rac1 signaling in the cerebellum. This particular role of Rac1 may be more widespread in the nervous system because Rac1 deficiency in the forebrain also results in an increased rate of apoptosis (Chen et al., 2009 ). However, this study revealed a positive role of Rac1 in proliferation, whereas our study shows that Rac1 is dispensable for proliferation during cerebellar development. Together, this suggests that regulation of cell proliferation by Rac1 may be more cell type specific.
Rac1 ablation from the nervous system impairs axon growth Previous in vitro studies suggested Rac1 as both a positive and a negative regulator of axonogenesis (Govek et al., 2005) . These discrepancies may stem from differences in the cellular systems analyzed or may be attributable to the fact that most of the previous studies used dominant-negative and constitutively active mutants, which can exhibit nonspecific or nonphysiological effects resulting from perturbation of multiple Rho GTPases (Wang and Zheng, 2007) .
Analysis in mice have shown that Rac1-deficient cortical neurons exhibit axon guidance defects and fail to cross the midline. However, axon growth defects could not be observed (Chen et al., 2007; Kassai et al., 2008) . One potential reason for the normal polarization of the Rac1-ablated cortical neurons is that Rac3 may compensate for some Rac1-dependent functions (Bolis et al., 2003; Corbetta et al., 2009) . Consistent with this view, knocking out Rac3 alone does not lead to defects in axon development (Corbetta et al., 2005; Gualdoni et al., 2007) . However, downregulation of Rac1, in the Rac3-knock-out neurons, revealed changes in dendrite development and spine formation (Gualdoni et al., 2007; Corbetta et al., 2009) . It is therefore possible that, in contrast to CGNs, axon formation in hippocampal neurons occurs independently of Rac1. Alternatively, some residual Rac1 activity could have still been present during axonal formation that occurs early during development (Bradke and Dotti, 2000) .
Our study clearly identifies Rac1 as a positive physiological regulator of axon growth in the mammalian nervous system. In addition to the in vivo defect in axon formation in the Rac1-knock-out cerebellum, cultured Rac1 Ϫ/Ϫ CGNs are disrupted in their polarization and show markedly reduced axon growth, indicating that this phenotype is cell intrinsic.
Rac1 regulates axon formation through the actin cytoskeleton
Axon outgrowth relies on coordinated regulation of the actin cytoskeleton and microtubule dynamics (da Silva and Dotti, 2002; Dent and Gertler, 2003; . Previous studies using mutant Rho-GTPases indicated that Rac1 may regulate both actin and microtubule dynamics (Kunda et al., 2001; Ng and Luo, 2004; Watabe-Uchida et al., 2006a,b) . However, although we did not study microtubule dynamics in detail, staining of the microtubules did not reveal any obvious defects in the microtubule organization, and microtubule stabilization did not rescue axon formation in the Rac1-knock-out CGNs (data not shown). Instead, we observed a strong defect in the organization and dynamics of the actin cytoskeleton in the growth cone. These Figure 9 . WAVE complex and its downstream effector Arp2/3 regulate axon growth downstream of Rac1. A, Dissociated CGNs were cotransfected with pEYFP-C1 and pcDNA3.1/myc-His A (ctrl) or with pEYFP-C1 and pWAVE-CAAX (pWAVE-CAAX). Cells were fixed at 3 DIV and immunostained for Tau-1 to visualize axons. On overexpression of WAVE-CAAX, Rac1 Ϫ/Ϫ CGNs extend significantly more Tau-1-positive axons bearing a typical proximodistal staining gradient. Instead, Rac1 Ϫ/Ϫ neurons transfected with the ctrl typically extend several shorter, Tau-1-negative neurites. Overexpression of WAVE-CAAX partially rescues the axon formation defect of Rac1 Ϫ/Ϫ CGNs. Scale bar, 25 m. B, Quantification of axon formation on transfection of pWAVE-CAAX or ctrl. Cells, bearing at least one Tau-1-positive axon (proximodistal staining gradient), were scored as positive. The values represent averages Ϯ SEM from four independent cultures (n ϭ 100 cells/culture; **p Ͻ 0.01; ***p Ͻ 0.001). C, Quantification of the length of the longest neurite in CGNs transfected with pWAVE-CAAX or ctrl. The values represent averages Ϯ SEM from five independent cultures (n ϭ 100 cells/culture; **p Ͻ 0.01). D, Time-lapse videomicroscopy of representative growth cones from wild-type CGNs cultured for 1 d and imaged before and after the addition of the Arp2/3 inhibitor (CK-548). The top panel represents four frames at 30 s intervals before the addition of CK-548, and the bottom panel, after the addition of CK-548. The additional two frames depict the growth cone dynamics 6 min before and after the inhibitor was added. Scale bar, 10 m.
